With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...
When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...
Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially ...
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 ...
Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...
Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...
Three health systems have filed federal lawsuits against CVS Health, alleging the company and several affiliates improperly diverted about $250 million in savings generated through the 340B drug ...
Nevada hospitals and health clinics say drug manufacturers are restricting the number of pharmacies in the state that can ...
Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results